Bharat Biotech has almost completed phase-2 trial for the nasal vaccine and it has shown good results, the pharma company's Chairman and MD said on Saturday. "We have almost completed phase 2 trials for the nasal vaccine and it has shown good results. The vaccine has received regulatory approval for second Phase trials in August. The adenoviral intranasal vaccine BBV154 is the first of its kind Covid-19 vaccine to undergo human trials in India. Trials for the Phase 3 trial will commence after the completion of Phase-2 clinical trials.

Source: Mint October 23, 2021 22:17 UTC